AB21
Supporting Your Immune Response

The probiotic strain AB21 is the first clinically validated for the treatment of Covid-19.

A Study including 300 non-hospitalized adult participants with PCR-confirmed COVID-19 and mild symptoms:

  • Remission rate, as measured by both the absence of COVID-19 symptoms and a negative RT-PCR test.

  • Reduction in the number of symptomatic patients with COVID-19.

  • Reduction in the duration of specific symptoms.

  • Reduced viral load in nasopharyngeal swabs.

  • Increased specific IgG and IgM levels against SARS-CoV-2.

The study is currently awaiting peer review.

More Info Coming Soon

Keep up to date with the latest news, clinically studies and product release date.